France Pirenne
Overview
Explore the profile of France Pirenne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamagne M, Khelfa M, Many S, Neyrinck-Leglantier D, Delorme A, Pinheiro M, et al.
Front Immunol
. 2025 Mar;
16:1509078.
PMID: 40028321
Introduction: The immunological profiles of CD4 T lymphocytes (TLs) from patients with hematological malignancies differ between patients who have and have not received transfusions. There may be several reasons for...
2.
Tournamille C, Muralitharan V, NetoBraga G, Bouly N, Levy C, Flahaut R, et al.
Transfusion
. 2024 Nov;
65(1):E1-E3.
PMID: 39601101
No abstract available.
3.
Diesch-Furlanetto T, Sanchez C, Atkinson A, Pondarre C, Dhedin N, Neven B, et al.
Blood Adv
. 2024 Jul;
8(19):5227-5235.
PMID: 39023361
The impact of hydroxyurea (HU) on the ovarian reserve of female patients with sickle cell disease (SCD) remains poorly elucidated. Only direct histological analysis of ovarian follicle density can effectively...
4.
Delorme A, Laguide A, Tamagne M, Pinheiro M, Cagnet L, Neyrinck-Leglantier D, et al.
Front Immunol
. 2024 Jul;
15:1397967.
PMID: 38947317
Introduction: CD39 plays an important role in the immunoregulation and inhibition of effector cells. It is expressed on immune cells, including Tregs, and on extracellular vesicles (EVs) budding from the...
5.
Floch A, Galochkina T, Pirenne F, Tournamille C, de Brevern A
Front Chem
. 2024 Apr;
12:1360392.
PMID: 38566898
Blood group antigens of the RH system (formerly known as "Rhesus") play an important role in transfusion medicine because of the severe haemolytic consequences of antibodies to these antigens. No...
6.
Nguyen K, Matte A, Foresti R, Federti E, Kiger L, Lefebvre C, et al.
Blood
. 2024 Mar;
143(24):2544-2558.
PMID: 38518106
Acute hyperhemolysis is a severe life-threatening complication in patients with sickle cell disease (SCD) that may occur during delayed hemolytic transfusion reaction (DHTR), or vaso-occlusive crises associated with multiorgan failure....
7.
Neyrinck-Leglantier D, Tamagne M, Ben Rayana R, Many S, Vingert P, LeGagneux J, et al.
Front Immunol
. 2024 Mar;
15:1354065.
PMID: 38500878
Introduction: People living with HIV (PLWH) now benefit from combined antiviral treatments that durably control viral replication. These antiretroviral treatments decrease mortality and improve quality of life in PLWH, but...
8.
Le Gallo M, Moutereau S, Gentil M, Pirenne F
Transfus Clin Biol
. 2024 Mar;
31(3):130-134.
PMID: 38462030
Introduction: Transfusion has a central place in the treatment of patients with sickle cell disease (SCD). Matching blood groups of red blood cell (RBC) units with the blood groups of...
9.
Pirenne F, Pondarre C
Hematology Am Soc Hematol Educ Program
. 2023 Dec;
2023(1):653-659.
PMID: 38066873
Alloimmunization against red blood cell antigens and delayed hemolytic transfusion reaction (DHTR) are major barriers to transfusion in sickle cell disease (SCD). In SCD, DHTR is a potentially life-threatening. Blood...
10.
Beillat M, Durand-Zaleski I, Pirenne F, Benard S, Chillotti L, Galacteros F
Front Public Health
. 2023 Oct;
11:1215605.
PMID: 37808997
Sickle cell disease (SCD) is a genetic disorder of the hemoglobin resulting in chronic anemia, hemolysis, and vaso-occlusions. Its treatment mostly relies on hydroxycarbamide, transfusions, and stem cell transplantation. This...